Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R

Go back to Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R
(NASDAQ: OCUL) Delayed: 10.12 +0.15 (1.50%)
Previous Close $9.97    52 Week High $14.50 
Open $9.83    52 Week Low $4.04 
Day High $10.62    P/E N/A 
Day Low $9.80    EPS $0.00 
Volume 2,756,728